Table 4.
Treatment outcome among smear positive TB patients in China, 2017–2020.
| Year | Period | Sputum conversion rate after 2 months treatment | Cured rate | |||
|---|---|---|---|---|---|---|
| n (%) | p value | n (%) | p value | |||
| 2017 | •• | •• | 0•3277 | •• | 0•9080 | |
| Period 1 | 44368/46796(94•8%) | 46977/51677(90•9%) | ||||
| Period 2 | 38162/40485(94•3%) | 43836/48201(90•9%) | ||||
| Period 3 | 16685/17808(93•7%) | 17757/19571(90•7%) | ||||
| 2018 | •• | •• | 0•1602 | •• | 0•2300 | |
| Period 1 | 42605/45375(93•9%) | 46135/52048(88•6%) | ||||
| Period 2 | 37041/39886(92•9%) | 43324/49370(87•8%) | ||||
| Period 3 | 17723/19174(92•4%) | 15691/17925(87•5%) | ||||
| 2019 | •• | •• | 0•1917 | •• | 0•2022 | |
| Period 1 | 41938/44993(93•2%) | 46031/53226(86•5%) | ||||
| Period 2 | 36809/39897(92•3%) | 42570/49568(85•9%) | ||||
| Period 3 | 17293/18828(91•8%) | 15098/17734(85•1%) | ||||
| 2020 | •• | •• | 0•7475 | •• | 0•6159 | |
| Control | 41716/44816(93•1%) | 44252/51998(85•1%) | ||||
| Intensive | 33165/35423(93•6%) | 33862/39992(84•7%) | ||||
| Regular | 8771/9548(91•9%) | 10997/12988(84•7%) | ||||